Inventor · disambiguated record
John Lee
Also filed as: LEE JOHN · LEE JOHN RANDY · LEE JOHN T · LEE JOHN T S
9 granted patents·8 pending applications·68 citations·filing 1984–2024
82Inventor score
Top patents by PatentIndex Score
17 records- 0191US12077592B2GPRC5D chimeric antigen receptors and cells expressing the sameJANSSEN BIOTECH INC·Filed 2020·Granted Sep 3, 2024·3 cites·36 claims
- 0284US4552820ADisc mediaLIN DATA CORP·Filed 1984·Granted Nov 12, 1985·63 cites·20 claims
- 0379US11096998B2Chimeric antigen receptors comprising BCMA-specific fibronectin type III domains and uses thereofJANSSEN BIOTECH INC·Filed 2017·Granted Aug 24, 2021·1 cites·2 claims
- 0478US11161897B2Antigen binding regions against fibronectin type III domains and methods of using the sameJANSSEN BIOTECH INC·Filed 2018·Granted Nov 2, 2021·1 cites·1 claims
- 0578US2024262921A1Gprc5d chimeric antigen receptors and cells expressing the sameJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 0670US12269870B2Antigen binding regions against fibronectin type III domains and methods of using the sameJANSSEN BIOTECH INC·Filed 2021·Granted Apr 8, 2025·0 cites·4 claims
- 0770US2024124583A1Proteins Comprising Kallikrein Related Paptidase 2 Antigen Binding Domains And Their UsesJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 0861US12077585B2Proteins comprising kallikrein related peptidase 2 antigen binding domains and their usesJANSSEN BIOTECH INC·Filed 2020·Granted Sep 3, 2024·0 cites·96 claims
- 0961US2022031822A1Chimeric antigen receptors comprising bcma-specific fibronectin type iii domains and uses thereofJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 1059US2020332255A1Immortalized car-t cells genetically modified to eliminate t-cell receptor and beta 2-microglobulin expressionJANSSEN BIOTECH INC·Filed 2018·Application pending·0 cites
- 1159US2019175651A1Immortalized car-t cells genetically modified to elminate t-cell receptor and beta 2-microglobulin expressionJANSSEN BIOTECH INC·Filed 2018·Application pending·0 cites
- 1255US12162951B2Anti-idiotypic antibodies against anti-KLK2 antibodiesJANSSEN BIOTECH INC·Filed 2021·Granted Dec 10, 2024·0 cites·29 claims
- 1351US12030937B2Anti-idiotypic antibodies against anti-GPRC5D antibodiesJANSSEN BIOTECH INC·Filed 2021·Granted Jul 9, 2024·0 cites·30 claims
- 1451US2020093292A1Safety Wall HangerLEE JOHN T S·Filed 2018·Application pending·0 cites
- 1548US12071466B2Anti-human kallikrein-2 (hK2) chimeric antigen receptor (CAR) and methods of use thereofJANSSEN BIOTECH INC·Filed 2020·Granted Aug 27, 2024·0 cites·35 claims
- 1637US2013108355A1Joint device for rods and panelsLEE JOHN T S·Filed 2011·Application pending·0 cites
- 1734US2004200923A1Instrumentation supporting panelFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →